A retrospective examination of the US Food and Drug Administration’s clinical pharmacology reviews of oncology biologics for potential use of therapeutic drug monitoring

por Fleisher, Brett, Ait-Oudhia, Sihem
Publicado 2017

Current advances in biomarkers for targeted therapy in triple-negative breast cancer

por Fleisher, Brett, Clarke, Charlotte, Ait-Oudhia, Sihem
Publicado 2016

Chloroquine sensitizes MDA-MB-231 cells to osimertinib through autophagy–apoptosis crosstalk pathway

por Fleisher, Brett, Mody, Hardik, Werkman, Carolin, Ait-Oudhia, Sihem
Publicado 2019

In vitro to Clinical Translation of Combinatorial Effects of Doxorubicin and Abemaciclib in Rb-Positive Triple Negative Breast Cancer: A Systems-Based Pharmacokinetic/Pharmacodynam...

por Fleisher, Brett, Lezeau, Jovin, Werkman, Carolin, Jacobs, Brehanna, Ait-Oudhia, Sihem
Publicado 2021